Corrigendum to: MSTO 1 is a cytoplasmic pro-mitochondrial fusion protein (EMBO Molecular Medicine, (2017), 9, 7, (967-984), 10.15252/emmm.201607058)

Aniko Gal, Peter Balicza, David Weaver, Shamim Naghdi, Suresh K. Joseph, Péter Várnai, Tibor Gyuris, Attila Horváth, Laszlo Nagy, Erin L. Seifert, Maria Judit Molnar, György Hajnóczky

Research output: Contribution to journalComment/debatepeer-review

Abstract

Figure 1C and D, and Table EV1 are retracted along with their corresponding legend. The associated claims regarding the presence of MSTO1 mutation c.22 G > A (p.Val8Met) in the investigated patients and the direct link between this mutation and patients’ myopathy and ataxia phenotypes are retracted. “MSTO P1” and “MSTO P2” are changed into “P1” and “P2,” respectively, throughout the manuscript.

Original languageEnglish (US)
Article numbere17911
JournalEMBO Molecular Medicine
Volume15
Issue number8
DOIs
StatePublished - Aug 7 2023

ASJC Scopus subject areas

  • Molecular Medicine

Fingerprint

Dive into the research topics of 'Corrigendum to: MSTO 1 is a cytoplasmic pro-mitochondrial fusion protein (EMBO Molecular Medicine, (2017), 9, 7, (967-984), 10.15252/emmm.201607058)'. Together they form a unique fingerprint.

Cite this